295 related articles for article (PubMed ID: 25981348)
1. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study.
Chen JX; Su YA; Bian QT; Wei LH; Zhang RZ; Liu YH; Correll C; Soares JC; Yang FD; Wang SL; Zhang XY
Psychoneuroendocrinology; 2015 Aug; 58():130-40. PubMed ID: 25981348
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic-Related Prolactin Levels and Sexual Dysfunction in Mentally Ill Youth: A 3-Month Cohort Study.
Koch MT; Carlson HE; Kazimi MM; Correll CU
J Am Acad Child Adolesc Psychiatry; 2023 Sep; 62(9):1021-1050. PubMed ID: 36931560
[TBL] [Abstract][Full Text] [Related]
3. Adjunct Aripiprazole Reduces Prolactin and Prolactin-Related Adverse Effects in Premenopausal Women With Psychosis: Results From the DAAMSEL Clinical Trial.
Kelly DL; Powell MM; Wehring HJ; Sayer MA; Kearns AM; Hackman AL; Buchanan RW; Nichols RB; Adams HA; Richardson CM; Vyas G; McMahon RP; Earl AK; Sullivan KM; Liu F; Luttrell SE; Dickerson FB; Feldman SM; Narang S; Koola MM; Buckley PF; RachBeisel JA; McEvoy JP
J Clin Psychopharmacol; 2018 Aug; 38(4):317-326. PubMed ID: 29912799
[TBL] [Abstract][Full Text] [Related]
4. A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes.
Robinson DG; Gallego JA; John M; Petrides G; Hassoun Y; Zhang JP; Lopez L; Braga RJ; Sevy SM; Addington J; Kellner CH; Tohen M; Naraine M; Bennett N; Greenberg J; Lencz T; Correll CU; Kane JM; Malhotra AK
Schizophr Bull; 2015 Nov; 41(6):1227-36. PubMed ID: 26338693
[TBL] [Abstract][Full Text] [Related]
5. Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents.
Calarge CA; Ellingrod VL; Acion L; Miller DD; Moline J; Tansey MJ; Schlechte JA
Pharmacogenet Genomics; 2009 May; 19(5):373-82. PubMed ID: 19339912
[TBL] [Abstract][Full Text] [Related]
6. Calcium and Vitamin D Supplementation in Boys with Risperidone-Induced Hyperprolactinemia: A Randomized, Placebo-Controlled Pilot Study.
Calarge CA; Mills JA; Ziegler EE; Schlechte JA
J Child Adolesc Psychopharmacol; 2018 Mar; 28(2):145-150. PubMed ID: 29112461
[TBL] [Abstract][Full Text] [Related]
7. L-Theanine adjunct to risperidone in the treatment of chronic schizophrenia inpatients: a randomized, double-blind, placebo-controlled clinical trial.
Shamabadi A; Fattollahzadeh-Noor S; Fallahpour B; A Basti F; Khodaei Ardakani MR; Akhondzadeh S
Psychopharmacology (Berl); 2023 Dec; 240(12):2631-2640. PubMed ID: 37697164
[TBL] [Abstract][Full Text] [Related]
8. Relapse in patients with schizophrenia and amisulpride-induced hyperprolactinemia or olanzapine-induced metabolic disturbance after switching to other antipsychotics.
Cai J; Li L; Shao T; Sun M; Wang W; Xie P; Wang X; Yang Y; Long Y; Kang D; Xiao J; Su Y; Peng X; Huang Y; Gao M; Wu Q; Song C; Liu F; Shao P; Ou J; Shen Y; Huang J; Wu R
Psychiatry Res; 2023 Apr; 322():115138. PubMed ID: 36871411
[TBL] [Abstract][Full Text] [Related]
9. Safety and Tolerability of Starting Aripiprazole Lauroxil With Aripiprazole Lauroxil NanoCrystal Dispersion in 1 Day Followed by Aripiprazole Lauroxil Every 2 Months Using Paliperidone Palmitate Monthly as an Active Control in Patients With Schizophrenia: A Post Hoc Analysis of a Randomized Controlled Trial.
Citrome L; Yagoda S; Bidollari I; Wang M
J Clin Psychiatry; 2024 Feb; 85(1):. PubMed ID: 38416865
[No Abstract] [Full Text] [Related]
10. Aggression Following Traumatic brain injury: Effectiveness of Risperidone (AFTER): study protocol for a feasibility randomised controlled trial.
Deb S; Leeson V; Aimola L; Bodani M; Li L; Weaver T; Sharp D; Crawford M
Trials; 2018 Jun; 19(1):325. PubMed ID: 29929537
[TBL] [Abstract][Full Text] [Related]
11. Editorial: A Better Perspective on Antipsychotic-Related Hyperprolactinemia in Children and Adolescents.
Strawn JR; Geracioti TD
J Am Acad Child Adolesc Psychiatry; 2023 Sep; 62(9):967-969. PubMed ID: 37172820
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic outcomes wide association scan of different antipsychotics in patients with schizophrenia: Randomized clinical trials and multi-ancestry validation.
Lu Z; Zhang Y; Sun Y; Liao Y; Kang Z; Feng X; Yan H; Wang L; Lu T; Zhang D; Yue W
Psychiatry Clin Neurosci; 2023 Sep; 77(9):486-496. PubMed ID: 37210704
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological treatment strategies for antipsychotic-induced hyperprolactinemia: a systematic review and network meta-analysis.
Lu Z; Sun Y; Zhang Y; Chen Y; Guo L; Liao Y; Kang Z; Feng X; Yue W
Transl Psychiatry; 2022 Jul; 12(1):267. PubMed ID: 35790713
[TBL] [Abstract][Full Text] [Related]
14. A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia.
Osmanova DZ; Freidin MB; Fedorenko OY; Pozhidaev IV; Boiko AS; Vyalova NM; Tiguntsev VV; Kornetova EG; Loonen AJM; Semke AV; Wilffert B; Bokhan NA; Ivanova SA
BMC Med Genet; 2019 Apr; 20(Suppl 1):47. PubMed ID: 30967134
[TBL] [Abstract][Full Text] [Related]
15. The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.
Peuskens J; Pani L; Detraux J; De Hert M
CNS Drugs; 2014 May; 28(5):421-53. PubMed ID: 24677189
[TBL] [Abstract][Full Text] [Related]
16. Evidence-Based Recommendations for the Pharmacological Treatment of Women with Schizophrenia Spectrum Disorders.
Brand BA; Willemse EJM; Hamers IMH; Sommer IE
Curr Psychiatry Rep; 2023 Nov; 25(11):723-733. PubMed ID: 37864676
[TBL] [Abstract][Full Text] [Related]
17. Risperidone combination therapy with adalimumab for treatment of chronic schizophrenia: a randomized, double-blind, placebo-controlled clinical trial.
Motamed M; Karimi H; Sanjari Moghaddam H; Taherzadeh Boroujeni S; Sanatian Z; Hasanzadeh A; Khodaei Ardakani MR; Akhondzadeh S
Int Clin Psychopharmacol; 2022 May; 37(3):92-101. PubMed ID: 35258035
[TBL] [Abstract][Full Text] [Related]
18. Normalization of risperidone-induced hyperprolactinemia with the addition of aripiprazole.
Shores LE
Psychiatry (Edgmont); 2005 Mar; 2(3):42-5. PubMed ID: 21179629
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological hyperprolactinemia: a retrospective analysis of 501 hyperprolactinemia cases in primary care setting.
García Cano AM; Rosillo M; Gómez Lozano A; Jiménez Mendiguchía L; Marchán Pinedo M; Rodríguez Torres A; Araujo-Castro M
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3239-3246. PubMed ID: 37910184
[TBL] [Abstract][Full Text] [Related]
20. The effect of antipsychotic medication and the associated hyperprolactinemia as a risk factor for periodontal diseases in schizophrenic patients: a cohort retrospective study.
Shalaby R; Elmahdy A; Mikhail C
BMC Oral Health; 2023 Oct; 23(1):786. PubMed ID: 37875841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
